Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Sep;118(3):372-8.
doi: 10.1111/bju.13329. Epub 2015 Oct 26.

Symptom burden and information needs in prostate cancer survivors: a case for tailored long-term survivorship care

Affiliations

Symptom burden and information needs in prostate cancer survivors: a case for tailored long-term survivorship care

Jennifer K Bernat et al. BJU Int. 2016 Sep.

Abstract

Objectives: To determine the relationship between long-term prostate cancer survivors' symptom burden and information needs.

Patients and methods: We used population-based data from the Michigan Prostate Cancer Survivor Study (2499 men). We examined unadjusted differences in long-term information needs according to symptom burden and performed multivariable logistic regression to examine symptom burden and information needs adjusting for patient characteristics.

Results: High symptom burden was reported across all domains (sexual 44.4%, urinary 14.4%, vitality 12.7%, bowel 8.4%, emotional 7.6%) with over half of respondents (56%) reporting they needed more information. Top information needs involved recurrence, relationships, and long-term effects. Prostate cancer survivors with high symptom burden more often searched for information regardless of domain (P < 0.05). High sexual burden was associated with greater need for information about relationships [odds ratio (OR) 2.05, 95% confidence interval (CI) 1.54-2.72] and long-term effects (OR 1.60, 95% CI 1.23-2.07). High bowel burden was associated with greater information need for long-term effects (OR 2.28, 95% CI 1.43-3.63).

Conclusions: Long-term prostate cancer survivors with high symptom burden need more supportive information. Tailoring information to these needs may be an efficient approach to support the growing population of long-term prostate cancer survivors.

Keywords: information needs; quality; self-management; survivorship; tailoring.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Information need differences between prostate cancer survivors with low versus high domain-specific symptom burden. When stratifying by symptom burden level and domain, individuals with high symptom burden compared to low symptom burden were more likely to need more information on at least one of the leading topics (i.e., recurrence of prostate cancer, effects on spouse/relationship, and long term effects/recovery from cancer) regardless of the specific domain (*p < .05).

Comment in

References

    1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2010 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet] Lyon, France: International Agency for Research on Cancer; 2013. [cited 2015 Jun 5]. Available from: Available from: http://globocan.iarc.fr.
    1. Bray F, Ren JS, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013;132(5):1133–45. - PubMed
    1. Resnick MJ, Koyama T, Fan KH, Albertsen PC, Goodman M, Hamilton AS, et al. Long-term functional outcomes after treatment for localized prostate cancer. The New England journal of medicine. 2013;368(5):436–45. - PMC - PubMed
    1. Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, et al. Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors. New England Journal of Medicine. 2008;358(12):1250–61. - PubMed
    1. Gore JL, Kwan L, Lee SP, Reiter RE, Litwin MS. Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer. Journal of the National Cancer Institute. 2009;101(12):888–92. - PubMed

Publication types